Status:
UNKNOWN
Validation of myStrength's Macropersonalization Engine
Lead Sponsor:
Teladoc Health
Conditions:
Depression, Anxiety
Trauma
Eligibility:
All Genders
18-85 years
Brief Summary
This is a study to validate myStrength's macropersonalization algorithm. Specifically, the study seeks to answer: Does myStrength's macropersonalization algorithm match what a clinician would offer as...
Detailed Description
Rationale and Background: Macropersonalization refers to the rules applied to a member's onboarding data that dictate their primary clinical focus and available interventions that will be recommended....
Eligibility Criteria
Inclusion
- Aged 18 to 85, inclusive
- Able to read, write, and speak in English
- Has access to the Internet to complete study procedures
- Currently engaged in therapy or has schedule an initial appointment with the Pacific Anxiety Group
Exclusion
- None
Key Trial Info
Start Date :
May 1 2022
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
March 31 2023
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT05417178
Start Date
May 1 2022
End Date
March 31 2023
Last Update
June 14 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Pacific Anxiety Group
Menlo Park, California, United States, 94025